DR. LISA LOUISE MCCLUSKEY, M.D.

Plain English
This study examined how damage to a specific nerve affects taste buds and the immune response in mice. Researchers found that two to five days after nerve injury, certain immune cells that help with healing increased in normal mice but not in genetically modified mice lacking a key signaling pathway. Although taste buds started to deteriorate at the same rate in both groups, the presence of healing immune cells in normal mice may aid in later recovery of taste function. Who this helps: This research benefits patients with taste loss due to nerve injuries, helping doctors understand how to better support recovery.

Plain English
This study looked at how chronic myeloid leukaemia (CML) affects certain immune cells called macrophages in the bone marrow. The researchers found that these CML-exposed macrophages showed a unique pattern of behavior, such as having lower levels of a key surface marker (CD36), which led to a reduced ability to clear dying cells in the bone marrow. This matters because less effective clearance of cells can worsen the disease environment and impact the body's ability to fight cancer. Who this helps: This helps patients with chronic myeloid leukaemia.

Plain English
This study looked at adjacent segment disease, which happens when a spinal segment next to a previously fused area starts to deteriorate and causes new symptoms like pain or instability. Researchers found that this condition can be influenced by factors such as the patient's individual characteristics and surgical techniques used. Understanding these factors is important because it informs treatment options, with non-surgical methods being preferred initially, but sometimes surgery is necessary to relieve symptoms. Who this helps: This helps patients who have had spinal fusion surgery and may experience new symptoms afterward.

Plain English
This study looked at a rare condition where the body makes blood cells outside of the usual places, causing growths in the spine, in a 63-year-old woman with specific blood disorders. After seven months of being asymptomatic, she suddenly experienced severe spinal cord compression and a fracture in her spine, which was treated successfully through urgent surgery. This shows that even patients without symptoms can suddenly face serious issues from this condition, highlighting the need for careful monitoring and consideration of surgery even when patients seem stable. Who this helps: This benefits patients with blood disorders and their doctors by emphasizing the need for awareness and timely intervention.

Plain English
This study examined how certain genetic variations are linked to cognitive problems in patients with amyotrophic lateral sclerosis (ALS). Researchers found that a specific score based on these genetic variations was associated with both cognitive decline over time and changes in brain structure in key areas related to thinking and memory. This is important because it helps us understand the genetic factors that may contribute to cognitive issues in ALS, potentially leading to better care and treatment for patients. Who this helps: Patients with ALS and their doctors.

Plain English
This study looked at a protein called neurofilament light chain (NfL) found in the cerebrospinal fluid of patients with a brain condition known as frontotemporal lobar degeneration (FTLD). Researchers found that higher levels of NfL were linked to worsening cognitive abilities in patients with a specific type of FTLD (FTLD-TDP), while for another type (FTLD-tau), the connection was mainly seen in certain thinking skills. This is important because it helps doctors diagnose and predict how patients with FTLD will progress over time, which can inform treatment decisions. Who this helps: This helps patients with frontotemporal lobar degeneration and their doctors.

Plain English
This study looked at how speech is affected in people with amyotrophic lateral sclerosis (ALS) and related disorders, focusing on both motor and cognitive issues. The researchers analyzed speech samples from 213 people and found that those with ALS had a reduced range of voice pitch and longer pauses when speaking, which were linked to the severity of their cognitive problems. Specifically, ALS patients showed a significant reduction in voice pitch range, with a connection to the health of certain brain areas. Who this helps: This research benefits patients with ALS and their doctors by improving understanding of how speech issues relate to both cognitive and motor impairments.

Plain English
Researchers set up a large registry to study primary lateral sclerosis (PLS), a rare neurodegenerative disease affecting motor function. They gathered data on 250 patients over about three years and found that patients lost an average of 1.6 points per year in their ability to function and experienced a 3% decline in breathing capacity annually. This information is crucial as it helps better understand how PLS progresses, which can guide future clinical trials and improve patient care. Who this helps: This benefits patients with PLS and their doctors by providing valuable insights into the disease.

Plain English
This study looked at the neurological symptoms associated with COVID-19, such as confusion and loss of smell and taste. Researchers found that SARS-CoV-2, the virus that causes COVID-19, may affect the brain, as it can bind to certain cells in the human brain and could potentially lead to long-term neurological issues. This is important because it highlights the need for further research to understand the lasting effects of COVID-19 on brain health. Who this helps: This helps patients recovering from COVID-19 and doctors treating them.

Plain English
This study looked at levels of a protein called GAP-43 in the cerebrospinal fluid of people with Alzheimer's disease compared to healthy individuals and those with other neurodegenerative conditions. The researchers found that GAP-43 levels were significantly higher in Alzheimer's patients (275 individuals) compared to healthy controls (43 individuals) and most others with neurodegenerative diseases (344 individuals). These findings indicate that measuring GAP-43 could help detect Alzheimer's earlier and track its progression more accurately. Who this helps: This benefits patients with Alzheimer's and their doctors by providing a potential tool for earlier diagnosis and monitoring of the disease.

Plain English
This study looked at a specific genetic variation (rs12608932) in people with sporadic amyotrophic lateral sclerosis (ALS) to see if it is linked to frontotemporal degeneration (FTD), which affects cognitive function and is often associated with a shorter lifespan. The researchers found that people carrying this genetic variation had reduced thickness in certain brain areas and performed worse on cognitive tests. They also found that these individuals had more severe brain damage related to ALS. This matters because understanding the role of this genetic factor could help doctors assess disease progression and tailor treatments more effectively. Who this helps: This helps patients with ALS and their families by providing insights into their condition and care options.

Plain English
This study looked at levels of a protein called neurofilament light (NFL) in the spinal fluid of 913 people to see how it relates to cognitive decline in various neurodegenerative diseases, like Alzheimer's and motor neuron disease. The researchers found that NFL levels were higher in patients with worse cognitive function; for example, patients with Alzheimer's had an average NFL level of 951 pg/mL, compared to 536 pg/mL in healthy controls. This matters because it suggests that measuring NFL in spinal fluid can help track the seriousness of cognitive decline in these conditions. Who this helps: This helps patients and doctors by providing a way to better understand and monitor neurodegenerative diseases.

Plain English
This research looked at how to tell if adults with sepsis need extra fluids, without them being on a ventilator. Out of nearly 27,000 articles, 14 studies with 594 patients were selected, but researchers found no clear agreement on the best tests to assess whether these patients need fluid. This is important because while giving fluids can save lives in sepsis, giving too much can be harmful, so more precise methods are needed to ensure patient safety. Who this helps: This research benefits doctors treating patients with sepsis.

Plain English
This study explored blood markers to help diagnose and track the progression of Parkinson's disease (PD). Researchers analyzed blood samples from 141 people with PD and 45 healthy individuals, measuring over 1,100 proteins. They found that four specific proteins—bone sialoprotein, osteomodulin, aminoacylase-1, and growth hormone receptor—were strongly linked to PD and could help identify patients at higher risk for cognitive decline; for example, low levels of growth hormone receptor increased the risk of developing mild cognitive impairment by more than twice. Who this helps: This research benefits patients with Parkinson's disease and their doctors by potentially improving diagnosis and monitoring of the disease.

Plain English
This research studied how a protein found in the cerebrospinal fluid (CSF), called α-synuclein, can help distinguish Alzheimer's disease (AD) from other similar disorders. The study involved 367 participants and found that combining levels of α-synuclein with standard AD markers increased diagnostic accuracy to around 90%, making it easier to identify Alzheimer's compared to frontotemporal dementia and Lewy body disorders. This is important because better diagnosis can lead to more appropriate treatments for patients. Who this helps: Patients with Alzheimer's disease and related disorders.

Plain English
This study looked at levels of a protein called neurogranin (Ng) in the cerebrospinal fluid of 915 patients diagnosed with various neurodegenerative diseases, including Alzheimer's disease (ADD), Parkinson's disease, and frontotemporal dementia. The researchers found that Ng levels were significantly higher in patients with ADD compared to those with other diseases, with a difference that was highly statistically significant (p < 0.0001). This finding is important because it suggests that measuring Ng in cerebrospinal fluid could help doctors better diagnose Alzheimer's disease and understand its progression. Who this helps: Patients with Alzheimer's disease and their doctors.

Plain English
Researchers studied brain alterations in patients with amyotrophic lateral sclerosis (ALS) and a type of dementia called behavioral variant frontotemporal dementia (bvFTD) that share similar protein issues. They found that patients with bvFTD had less brain thickness and specific areas of reduced blood flow, while ALS patients showed different blood flow changes but no reduction in brain thickness. These findings are important because they suggest that changes in blood flow patterns can provide early signs of brain damage in these conditions, which could help in early diagnosis and treatment. Who this helps: This helps patients with ALS and bvFTD by improving early detection and potentially guiding treatment strategies.

Plain English
This study looked at the presence of different brain protein issues (called proteinopathies) in 766 people who had various neurodegenerative diseases. It found that the majority of these individuals had multiple types of these protein issues at the same time: tau protein was found in nearly all cases (92-100%), while amyloid-β was present in 20-57%, and TDP-43 was rarely seen (0-16%). This is important because it shows that older age and a specific gene variant (APOE4) increase the risk of having more than one protein problem, which can complicate treatments and the understanding of these diseases. Who this helps: This helps patients with neurodegenerative diseases and their doctors in understanding the complexity of their conditions.

Plain English
This research developed a shorter version of a questionnaire specifically designed to measure the quality of life for patients with Amyotrophic Lateral Sclerosis (ALS). The new tool, called the ALSSQOL-SF, includes 20 questions and takes only 2-4 minutes to complete, compared to 15-25 minutes for the longer version. It is effective at providing important insights into the lives of ALS patients while being more manageable in clinical settings. Who this helps: This benefits ALS patients and their healthcare providers by saving time and still capturing important health information.

Plain English
This study looked at the genetics of amyotrophic lateral sclerosis (ALS) by analyzing DNA from nearly 36,000 people, including over 12,000 with ALS. Researchers discovered a new genetic risk factor on chromosome 21 linked to the disease and identified three genes that might increase ALS risk. This matters because understanding the genetic causes of ALS can help in developing better treatments or strategies for prevention. Who this helps: This helps patients with ALS and their families.

Plain English
This study looked at the role of a genetic change called C9orf72 hypermethylation in people with a specific genetic mutation linked to diseases like frontotemporal dementia (FTD). Researchers found that individuals with C9orf72 hypermethylation had a later age of death and longer disease duration; specifically, brain hypermethylation was associated with a 0.18-year increase in life expectancy, and blood hypermethylation correlated with an increased disease duration. These findings highlight the potential for C9orf72 hypermethylation to lessen the severity of FTD symptoms, suggesting that reducing the harmful effects of this mutation could lead to better clinical outcomes for patients. Who this helps: This helps patients with frontotemporal dementia and their families.

Plain English
This study looked at how well people with amyotrophic lateral sclerosis (ALS) can form sentences compared to healthy seniors. It found that ALS patients struggle with speaking less, speaking slower, making more mistakes, and using correct grammar. Specifically, while their speech speed and errors are linked to muscle control issues, difficulties with grammar happen independently and relate to changes in certain brain areas. Who this helps: This research benefits patients with ALS and their healthcare providers by highlighting specific speech issues that may not be related to physical capability.

Plain English
This study looked at the genes linked to amyotrophic lateral sclerosis (ALS) by examining the DNA of 2,869 ALS patients and 6,405 healthy individuals. Researchers identified several genes related to ALS, including a new one called TBK1, which plays a crucial role in the body's immune response and waste management processes. This is important because it highlights specific biological pathways that could be targeted for new treatments for ALS. Who this helps: This benefits patients with ALS and researchers working on potential therapies.

Plain English
This study looked at patients with a specific genetic change known as C9orf72 repeat expansion to see if a chemical change (hypermethylation) in their DNA could protect their brain cells. Researchers found that those with higher levels of hypermethylation had less brain cell loss in key areas, such as the hippocampus and frontal cortex, and showed a slower decline in memory function over time. This is important because it suggests that targeting this hypermethylation could lead to new treatments for diseases linked to C9orf72, potentially slowing down brain damage. Who this helps: This helps patients with C9orf72-related diseases and their healthcare providers.

Plain English
This study looked at how people with amyotrophic lateral sclerosis (ALS) perform on a test of cognitive flexibility, which is the ability to switch thinking between different tasks. Researchers found that almost half of the ALS patients (48.2%) made errors on the test, and those who performed poorly had damage in specific areas of the brain. Understanding these cognitive challenges is important because it helps identify how ALS affects thinking skills, not just physical abilities. Who this helps: This helps patients and doctors by improving awareness of cognitive issues in ALS.

Plain English
This study looked at how well Mississippi has adopted proven treatment methods for substance abuse over a few years. Researchers found that while progress was made, with the use of evidence-based practices increasing from 47% to 61% among treatment providers, many professionals still face challenges in fully implementing these treatments. Understanding these successes and barriers is important because it helps improve treatment options for people struggling with addiction. Who this helps: Patients dealing with substance use disorders.

Plain English
This study focused on creating a biobank at the University of Pennsylvania to collect and share valuable information about neurodegenerative diseases, which are illnesses marked by harmful protein buildup in the brain. The researchers developed a system that gathers not just brain tissue, but also other biological samples and detailed patient information, making it easier to study these diseases in a comprehensive way. This is important because it helps scientists connect brain changes with symptoms, leading to better understanding and potential treatments for neurodegenerative disorders. Who this helps: This helps researchers and doctors working on neurodegenerative diseases.

Plain English
This study looked at how certain genetic factors are linked to changes in brain structure in patients with a form of dementia called frontotemporal lobar degeneration (FTLD). Researchers found that a specific genetic variant (rs8070723) was associated with gray matter changes in the temporal cortex, while other genetic variants (rs1768208, rs646776, and rs5848) were connected to white matter changes in the brain. Understanding these associations is important because they can help identify the underlying causes of FTLD and guide future treatments. Who this helps: This benefits patients with FTLD and their doctors by improving diagnostic tools and treatment strategies.

Plain English
This study looked at how a specific genetic variant, TMEM106B, affects the progression and timing of frontotemporal lobar degeneration (FTLD) in people with a common genetic mutation (C9orf72). Researchers found that individuals with a certain form of the TMEM106B gene (the major allele) had a later age at both onset of symptoms and death—specifically, those with this variant lived longer, with findings showing a correlation of later death in 75 patients tested internationally. Understanding these genetic influences is important because it could help predict disease progression and improve care for those affected by these neurodegenerative diseases. Who this helps: Patients with frontotemporal lobar degeneration and their families.

Plain English
This study examined a potential new test that could help identify amyotrophic lateral sclerosis (ALS) more accurately. Researchers measured levels of a protein called phosphorylated tau in the spinal fluid of 51 ALS patients and 23 individuals with a related condition. They found that ALS patients had significantly lower levels of this protein, with a test result accuracy of 92% sensitivity and 92% specificity, demonstrating it's a reliable indicator for diagnosing ALS. Who this helps: This benefits patients suspected of having ALS, as it may lead to more accurate and timely diagnoses.

Plain English
This study examined how patients with amyotrophic lateral sclerosis (ALS) and Parkinson's disease (PD) understand action verbs, which are words that describe actions like "run" or "jump." Researchers found that 36 ALS patients struggled significantly with action verbs compared to healthy older adults, while the 22 PD patients showed no difference in understanding any types of words. These results suggest that the problems ALS patients face with action verbs may be linked to brain changes in areas responsible for motor functions. Who this helps: This helps ALS patients and their caregivers by highlighting specific language challenges they might face.

Plain English
This study looked at the presence of a protein linked to nerve damage (pTDP-43) and the loss of nerve cells in the spinal cords of 36 patients with amyotrophic lateral sclerosis (ALS) compared to 10 healthy individuals. It found that severe nerve damage and pTDP-43 accumulations were most pronounced in specific areas of the spinal cord, particularly in regions related to motor control, with different patterns depending on whether patients had symptoms starting in their arms or legs. This matters because it helps identify early signs of ALS and may improve understanding of how the disease progresses. Who this helps: Patients with ALS and their doctors.

Plain English
The study looked at how well people with amyotrophic lateral sclerosis (ALS) tell stories compared to healthy older adults. Researchers found that ALS patients struggled with organizing their thoughts and maintaining a coherent narrative, performing worse than controls in specific measures like "local connectedness." This issue is linked to problems in certain brain areas and is connected to cognitive (thinking) difficulties rather than physical motor issues, highlighting that ALS affects more than just movement. Who this helps: This information helps patients and their families understand the cognitive challenges associated with ALS.

Plain English
This study looked at a group of 550 patients with amyotrophic lateral sclerosis (ALS) to understand ALS-Plus syndrome, which includes symptoms beyond the usual muscle and nerve issues, such as problems with eye movement and balance. Out of the patients, 75 (about 14%) had ALS-Plus syndrome, and these individuals tended to have more cognitive impairment, a faster disease progression (29.66 months of survival compared to 42.50 months for those without ALS-Plus), and a higher chance of having certain genetic mutations. This research highlights that ALS can affect multiple systems and that ALS-Plus patients face greater health challenges and shorter lives. Who this helps: This helps patients and doctors understand the broader impact of ALS and manage care more effectively for those with ALS-Plus syndrome.

Plain English
This study looked at how brain changes in patients with Amyotrophic Lateral Sclerosis (ALS) relate to motor function, specifically focusing on upper motor neuron disease. Researchers examined 34 ALS patients using imaging techniques to measure brain activity and found that both the Mean Diffusivity and Fractional Anisotropy values were closely linked to clinical assessments of upper motor neuron function, with results showing that higher Penn UMN Scores correlated with specific brain changes. These findings matter because they provide a clearer understanding of how brain imaging can reflect disease progression in ALS, potentially leading to better monitoring of patient health. Who this helps: This helps patients and their doctors by offering insights into disease progression and assessment.

Plain English
This study looked at how the protein pTDP-43 spreads through the brains of people who had amyotrophic lateral sclerosis (ALS). Researchers found that this protein's presence increases in a specific order across four stages: starting from the motor cortex and advancing to areas like the prefrontal neocortex and hippocampus. Understanding these stages is important because it may help track the disease's progression and explain cognitive issues that ALS patients often experience. Who this helps: This helps patients and doctors by providing insights into disease progression.

Plain English
This study looked at amyotrophic lateral sclerosis (ALS), a disease that causes progressive muscle weakness. It found that ALS has different forms, like typical ALS and primary lateral sclerosis, but all these forms share some key biological features, such as the presence of a protein called TDP-43. Understanding the different ways ALS appears and its underlying causes is important because it could lead to better treatments that stop or slow the disease. Who this helps: This helps patients with ALS and their families, as well as doctors seeking effective therapies.

Plain English
This research paper examines patients who are fully aware and conscious but cannot communicate or move due to serious nerve or muscle disorders. It highlights conditions like locked-in syndrome, high cervical spinal cord injury, and amyotrophic lateral sclerosis, stressing the need for doctors to recognize their patients’ awareness and to help them communicate and make decisions about their care. Understanding these ethical challenges is crucial to ensuring that these patients receive proper treatment that respects their rights and dignity. Who this helps: This helps patients with severe communication difficulties and the doctors caring for them.

Plain English
This study looked at a specific genetic mutation (NIPA1) linked to a condition called hereditary spastic paraplegia (HSP) in one patient, who also showed signs of motor neuron disease and cognitive decline. The researchers found damage in the nervous system and abnormal protein clumps associated with TDP-43, a protein linked to several neurodegenerative diseases. This is important because it highlights a potential new understanding of how certain genetic mutations can cause serious neurological issues. Who this helps: This helps patients with hereditary spastic paraplegia and their doctors by providing insights into their condition.

Plain English
This study looked at how common a specific genetic mutation called the C9orf72 hexanucleotide repeat expansion is among patients with amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). Among nearly 4,500 ALS patients, the mutation was found in 7% of those without family history (mostly white individuals) and in 39% of those with a family history. For FTD patients, 6% of those without family history and nearly 25% of those with it tested positive for the mutation. Understanding the frequency of this genetic change is important because it helps doctors provide better care and counseling for patients and their families regarding these serious diseases. Who this helps: This helps patients with ALS and FTD, as well as their families and doctors involved in their care.

Plain English
This study looked at a specific genetic mutation (C9ORF72 expansion) in patients with amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD) to see how it affects the disease and the brain’s pathology. Researchers found that about 19.4% of ALS patients and 31% of FTLD patients had this genetic expansion, and those with the expansion often experienced a faster decline in health and more severe symptoms. The unique patterns of certain proteins in their brain cells could help identify these patients and indicate a worse prognosis. Who this helps: This helps patients with ALS and FTLD by providing insights into their genetic profile and expected disease progression.

Plain English
This study looked at a gene called EWSR1 and its possible involvement in amyotrophic lateral sclerosis (ALS), a serious disease that damages nerve cells and leads to muscle weakness. Researchers found that three specific changes in the EWSR1 gene were present in ALS patients but not in many healthy people, meaning these changes might be linked to the disease. They also discovered that these genetic changes affect how EWSR1 behaves in nerve cells and that EWSR1 shows similar harmful traits as other proteins previously linked to ALS. Who this helps: This research benefits ALS patients and may help doctors understand the disease better.

Plain English
This study looked at why some patients with ALS need feeding tubes or breathing tubes inserted during emergency hospital visits, particularly focusing on trends from 1996 to 2009. The researchers found that 32% of feeding tubes and 67% of breathing tubes were inserted in emergencies, and that Black and Medicaid patients had a higher chance of needing these procedures urgently. This is important because emergency procedures are often more expensive and lead to fewer patients returning home successfully after their hospital stay. Who this helps: This helps ALS patients and their families by highlighting disparities in care and the impact of hospital types on urgent medical needs.

Plain English
This study investigated how well some people with Amyotrophic Lateral Sclerosis (ALS) can form concepts and manage executive functions, like sorting information. The researchers tested 41 ALS patients and found that about one-third had mild impairment, while others performed at average or above average levels. They also discovered that thinning of certain brain areas was linked to poorer performance on specific tasks, indicating that cognitive difficulties are common in ALS. Who this helps: This helps patients and their families by providing insights into the cognitive challenges associated with ALS.

Plain English
This study looked at how certain brain cells called microglia are involved in the progression of amyotrophic lateral sclerosis (ALS), particularly in patients with specific genetic changes. Researchers found that patients with faster disease progression had more active microglia, shown by a significant increase in scores related to motor function – the higher the score on the clinical scale, the more microglial pathology was observed. This is important because understanding the role of microglial activity could help in developing targeted therapies for ALS. Who this helps: This helps ALS patients and their doctors by providing insights for better treatment approaches.

Plain English
This study looked at how problems in the frontal lobe of the brain, as seen on a specific brain scan (MRS), relate to difficulties in generating words in ALS patients. Out of 25 patients studied, 50% showed poor letter fluency, and those with this impairment had lower levels of a brain chemical (N-acetyl aspartate) in an important brain region compared to those who performed well. These findings highlight that brain health can impact cognitive abilities in ALS patients, which can help in understanding and managing the disease better. Who this helps: This helps ALS patients and their doctors.

Plain English
This study looked at blood tests to see if certain proteins in the plasma can help diagnose Alzheimer's disease (AD) and mild cognitive impairment (MCI). Researchers tested 190 proteins in blood samples from 600 people and found 17 proteins linked to early signs of dementia, with four key proteins (apoE, B-type natriuretic peptide, C-reactive protein, and pancreatic polypeptide) showing consistent changes across multiple groups. This is important because identifying these blood markers could lead to earlier and more accurate diagnoses of Alzheimer's and could help monitor disease progression. Who this helps: This helps patients and doctors by providing potential new tools for diagnosing and tracking Alzheimer's disease.